EpiVax partners with Intravacc, CEPI for betacoronavirus vaccine development

EpiVax will identify cross-reactive beta-coronavirus T cell epitopes for Covid-19, MERS and SARS Class 1 and Class 2 HLA-restricted epitopes. Credit: National Cancer Institute on Unsplash.